About Culture Biosciences
Culture Biosciences is a Healthcare company based in San Francisco (United States) founded in 2016. Biomanufacturing hardware and software tools are provided for research purposes. Culture Biosciences has raised $107.22 million across 6 funding rounds from investors including Verily, TPB and Synthesis Capital. The company has 35 employees. Its chief executive, as recorded, is Chris Williams. Its website culturebiosciences.com draws about 27 thousand monthly visits. Culture Biosciences offers products and services including Stratyxâ„¢, Console, and Nexxysâ„¢. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Bioreactors. Its legal entity is CULTURE BIOSCIENCES, INC. Its competitors include Avidity Biosciences, Sutro Biopharma and Vividion Therapeutics; 3 of its 3 listed competitors have raised funding.
Company details
Culture Biosciences was founded in 2016 in San Francisco, United States, and operates in the biomanufacturing sector. A digital platform has been developed by the company, integrating automated bioreactors, robotic sample handling, and cloud-based data monitoring. Services offered include strain screening, media optimization, and process development to support research activities.
- Headquarters San Francisco, United States
- Employees 35
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website culturebiosciences.com
- Social LinkedIn X
- Legal Name Culture Biosciences, Inc.
- Total Equity Funding$107.22M (USD)
in 6 rounds
- InvestorsVerily
& 13 more
- Employee Count35
Products & Services of Culture Biosciences
Culture Biosciences offers a comprehensive portfolio of products and services, including Stratyx™, Console, and Nexxys™.
Cloud-integrated mobile bioreactor for cell culture process development.
Cloud-based system for bioprocess management and data analytics.
Lab-based system for bioprocess experiments and optimization.
Funding Insights of Culture Biosciences
Culture Biosciences has successfully raised a total of $107.22M across 6 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $107.22M
- Total Rounds 6
- First Round $120,000
(Jun 2018)
- Investors Count 14
All 6 funding rounds of Culture Biosciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2025 | Series C | – | – | ||
| Oct 2021 | $80M | Series B | – | Northpond Ventures | |
| Mar 2020 | $21.6M | Series A | – | Cultivian Sandbox | |
| Sep 2019 | $750,000 | Grant | – | – | |
| Feb 2019 | $5.5M | Series A | – | S32 | |
| Jun 2018 | $120,000 | Seed | – | Y Combinator | – |
14 investors in total: 14 institutional.
Investors in Culture Biosciences
Culture Biosciences has secured backing from 14 investors, including venture fund and institutional investors. Prominent investors backing the company include Verily, TPB and Synthesis Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| synthesiscapital.com | ||||
| cultiviansbx.com | ||||
Venture capital fund focused on SaaS and consumer sectors | craftventures.com | San Francisco, United States | ||
Research and manufacturing services in drug development are provided. | 2020 | tpb.co | San Francisco, United States | |
Investing in early-stage tech companies and ideas. | boxgroup.com | |||
Venture capital firm investing in life sciences & tech sectors | npv.vc | Cambridge, United States | ||
Tech startups are funded by S32, a venture capital entity. | s32.com | Sunnyvale, United States | ||
Early-stage startups are accelerated via funding and educational programs. | ycombinator.com | Mountain View, United States | ||
Venture capital fund backed by the US Government | seedfund.nsf.gov | Alexandria, United States | ||
Seed and early-stage investments are made across US and India. | refactor.com | Burlingame, United States |
Investor details for Culture Biosciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Culture Biosciences
37 people are tracked at Culture Biosciences (15 in leadership, 22 in team); the tracked headcount is 35.
| Name | Role | Group |
|---|---|---|
Chris Williams | CEO | Leadership |
Brooke Thorson | Director Of Supply Chain And Manufacturing | Leadership |
Jeffrey Thayer | Director, Hardware Engineering | Leadership |
Shawn Lichaa | Chief Administrative Officer & General Counsel | Leadership |
Heidi O'Neill | Sr Director And Corporate Controller | Leadership |
Matt Ball | CTO | Leadership |
Will Patrick | Co-Founder & CEO | Leadership |
Michael (Mike) Calma | Associate Director-bio Operations | Leadership |
Jason Gu | Director Of IT | Leadership |
Katie Greenfield | Interim VP, Finance | Leadership |
Rhett V. Pascual | Head of Quality | Leadership |
Murali Janakiraman | Director Of Software Engineering | Leadership |
Palmer Lam | Vice President Operations | Leadership |
Barbara Weaver | Human Resources Director | Leadership |
Lauren Kellogg | Chief of Staff | Leadership |
Michael Eng Hoe Khor | Software Engineer | Team |
Jessica Lee, PhD | Engineering Manager | Team |
Michael Chin | Senior Electrical Engineer I | Team |
Trevor Inshaw | Senior Field Service Engineer | Team |
Alice Vega | Senior Accountant | Team |
17 more people are available in the full profile.
Complete people profiles for Culture Biosciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Culture Biosciences
3 dated milestones of Culture Biosciences across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Culture Biosciences is founded.
- Funding First funding round of $120K.
- Funding Latest funding round, Series C,.
Competitors of Culture Biosciences
Culture Biosciences has 3 listed competitors in our database, 3 of them funded. They include Avidity Biosciences, Sutro Biopharma and Vividion Therapeutics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform |
Detailed competitors of Culture Biosciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Culture Biosciences
The website of Culture Biosciences (culturebiosciences.com) receives about 26.9K visits a month.
- Monthly visits26.9K
▲ 92% vs previous month
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Culture Biosciences (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Culture Biosciences
Complete news archive for Culture Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Culture Biosciences
Culture Biosciences was founded in 2016 and raised its 1st funding round 2 years after it was founded.
Culture Biosciences is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Chris Williams is the CEO of Culture Biosciences, as recorded in our data.
Culture Biosciences is a funded company, having raised a total of $107.22M across 6 funding rounds to date. The company's 1st funding round was a Seed of $120K, raised on Jun 2018.
Culture Biosciences has 35 employees.
Culture Biosciences was founded in 2016 in San Francisco, United States, and operates in the biomanufacturing sector. A digital platform has been developed by the company, integrating automated bioreactors, robotic sample handling, and cloud-based data monitoring. Services offered include strain screening, media optimization, and process development to support research activities.
Culture Biosciences's top competitors include Sutro Biopharma, Avidity Biosciences and Vividion Therapeutics.
Culture Biosciences offers Stratyxâ„¢, Console, and Nexxysâ„¢.
Culture Biosciences has 14 investors. Key investors include Verily, TPB, Synthesis Capital, Cultivian Sandbox, and Craft Ventures.
Culture Biosciences operates through Culture Biosciences, Inc..